Tiera Liby

512 total citations
9 papers, 196 citations indexed

About

Tiera Liby is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Tiera Liby has authored 9 papers receiving a total of 196 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Molecular Biology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Tiera Liby's work include HER2/EGFR in Cancer Research (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Advanced Breast Cancer Therapies (1 paper). Tiera Liby is often cited by papers focused on HER2/EGFR in Cancer Research (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Advanced Breast Cancer Therapies (1 paper). Tiera Liby collaborates with scholars based in United States, France and Canada. Tiera Liby's co-authors include Laura M. Heiser, Joe W. Gray, James E. Korkola, Moqing Liu, Rebecca Smith, Elmar Bucher, Mark Dane, Amanda Esch, Craig Beeson and Tien Hsu and has published in prestigious journals such as Nature Communications, Cancer Research and Scientific Reports.

In The Last Decade

Tiera Liby

9 papers receiving 191 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tiera Liby United States	7	122	81	43	43	30	9	196
Heidi M. Haikala Finland	7	212 1.7×	131 1.6×	36 0.8×	64 1.5×	39 1.3×	15	309
Tsunehisa Nomura Japan	9	121 1.0×	137 1.7×	37 0.9×	80 1.9×	25 0.8×	33	292
Andrew O. Giacomelli Canada	7	186 1.5×	98 1.2×	44 1.0×	57 1.3×	24 0.8×	9	275
Miquel Ensenyat-Méndez Spain	8	110 0.9×	95 1.2×	34 0.8×	90 2.1×	14 0.5×	19	221
Berthold Gierke Germany	8	148 1.2×	105 1.3×	32 0.7×	72 1.7×	18 0.6×	12	277
Noah Berlow United States	11	175 1.4×	78 1.0×	71 1.7×	46 1.1×	11 0.4×	34	305
Dominika Piasecka Poland	9	228 1.9×	103 1.3×	30 0.7×	152 3.5×	16 0.5×	16	308
Linlin Mao China	10	122 1.0×	79 1.0×	41 1.0×	62 1.4×	9 0.3×	27	228
Elizabeth McNeil United States	4	152 1.2×	86 1.1×	21 0.5×	44 1.0×	6 0.2×	6	221

Countries citing papers authored by Tiera Liby

Since Specialization

Citations

This map shows the geographic impact of Tiera Liby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tiera Liby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tiera Liby more than expected).

Fields of papers citing papers by Tiera Liby

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tiera Liby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tiera Liby. The network helps show where Tiera Liby may publish in the future.

Co-authorship network of co-authors of Tiera Liby

This figure shows the co-authorship network connecting the top 25 collaborators of Tiera Liby. A scholar is included among the top collaborators of Tiera Liby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tiera Liby. Tiera Liby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Calistri, Nicholas L., Tiera Liby, Zhi Hu, et al.. (2025). TNBC response to paclitaxel phenocopies interferon response which reveals cell cycle-associated resistance mechanisms. Scientific Reports. 15(1). 4294–4294. 1 indexed citations

Gross, Sean M., et al.. (2023). Analysis and modeling of cancer drug responses using cell cycle phase-specific rate effects. Nature Communications. 14(1). 3450–3450. 25 indexed citations

Liu, Moqing, Rebecca Smith, Tiera Liby, et al.. (2022). INHBA is a mediator of aggressive tumor behavior in HER2+ basal breast cancer. Breast Cancer Research. 24(1). 18–18. 7 indexed citations

Garay, Joseph P., Rebecca Smith, Kaylyn L. Devlin, et al.. (2021). Sensitivity to targeted therapy differs between HER2-amplified breast cancer cells harboring kinase and helical domain mutations in PIK3CA. Breast Cancer Research. 23(1). 81–81. 8 indexed citations

Smith, Rebecca, Moqing Liu, Tiera Liby, et al.. (2020). Enzalutamide response in a panel of prostate cancer cell lines reveals a role for glucocorticoid receptor in enzalutamide resistant disease. Scientific Reports. 10(1). 21750–21750. 38 indexed citations

Watson, Spencer S., Mark Dane, Koei Chin, et al.. (2018). Microenvironment-Mediated Mechanisms of Resistance to HER2 Inhibitors Differ between HER2+ Breast Cancer Subtypes. Cell Systems. 6(3). 329–342.e6. 50 indexed citations

Hassan, Saima, Amanda Esch, Tiera Liby, Joe W. Gray, & Laura M. Heiser. (2017). Pathway-Enriched Gene Signature Associated with 53BP1 Response to PARP Inhibition in Triple-Negative Breast Cancer. Molecular Cancer Therapeutics. 16(12). 2892–2901. 27 indexed citations

Korkola, James E., Moqing Liu, Tiera Liby, et al.. (2015). Abstract S6-07: Detrimental effects of sequential compared to concurrent treatment of pertuzumab plus T-DM1 in HER2+ breast cancer cell lines. Cancer Research. 75(9_Supplement). S6–7. 6 indexed citations

Liby, Tiera, et al.. (2011). Akt3 controls vascular endothelial growth factor secretion and angiogenesis in ovarian cancer cells. International Journal of Cancer. 130(3). 532–543. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact